Other
Research and development expense
Eli Lilly Research and development expense decreased by 7.7% to $3.51B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 28.4%, from $2.73B to $3.51B. Over 3 years (FY 2021 to FY 2025), Research and development expense shows an upward trend with a 24.4% CAGR.
Analysis
StatementIncome Statement
SectionOther
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2021
Last reportedQ1 2026Apr 30, 2026
How to read this metric
Higher spending typically signals a commitment to long-term innovation and future product pipelines, while significant cuts may signal a shift toward short-term profitability.
Detailed definition
This metric captures the investment in creating new products, improving existing technologies, and advancing internal ca...
Peer comparison
Standard metric for technology and hardware firms; highly comparable to R&D spending at peers.
Metric ID:
other_research_and_development_expense_excluding_acquire_88a3cdHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.73B | $1.73B | $1.73B | $1.80B | $2.00B | $1.99B | $2.36B | $2.41B | $2.56B | $2.52B | $2.71B | $2.73B | $3.02B | $2.73B | $3.34B | $3.47B | $3.80B | $3.51B |
| QoQ Change | — | +0.0% | +0.0% | +4.1% | +10.7% | -0.5% | +18.7% | +2.2% | +6.4% | -1.5% | +7.5% | +0.8% | +10.6% | -9.6% | +22.0% | +3.9% | +9.7% | -7.7% |
| YoY Change | — | — | — | +4.1% | +15.2% | — | — | +33.6% | +28.4% | +27.1% | +15.1% | +13.5% | +18.0% | +8.4% | +23.0% | +26.8% | +25.8% | +28.4% |
Range$1.73B – $3.80B
CAGR+18.1%
Avg YoY Growth+20.6%
Median YoY Growth+23.0%
Product Breakdown
| Segment | Q1 '25 |
|---|---|
| Late-stage | $1.74B |
| Early-stage | $990.00M |
| Total | $2.73B |
Research and development expense at Other Companies
Frequently Asked Questions
- What is Eli Lilly's research and development expense?
- Eli Lilly (LLY) reported research and development expense of $3.51B in Q1 2026.
- How has Eli Lilly's research and development expense changed year-over-year?
- Eli Lilly's research and development expense increased by 28.4% year-over-year, from $2.73B to $3.51B.
- What is the long-term trend for Eli Lilly's research and development expense?
- Over 3 years (2021 to 2025), Eli Lilly's research and development expense has grown at a 24.4% compound annual growth rate (CAGR), from $6.93B to $13.34B.
- What does research and development expense mean?
- Spending on innovation and product development.